coq was administered to children with preclinical muscular dystrophy , coq enzymology was emphasized , and serum creatine phosphokinase , cpk , ( atp : creatine n-phosphotransferase , ec 2.7.3.2 ) was repeatedly monitored.a 40-week treatment of an infant , 1-2 years of age , reduced serum cpk ( p < 0.001 ; total cpk assays , 76 ) .
C0008059
children
C0021270
infant